I

IDEAYA Biosciences

IDYA

42.470
USD
-0.61
(-1.42%)
مغلق
حجم التداول
22,988
الربح لكل سهم
0
العائد الربحي
0
P/E
-13
حجم السوق
2,414,481,099
أصول ذات صلة
A
ACRS
-0.03000
(-2.24%)
1.31000 USD
A
AGEN
-0.05000
(-0.83%)
5.99000 USD
A
AUPH
-0.28000
(-4.76%)
5.60000 USD
C
CRVS
0.36000
(13.85%)
2.96000 USD
N
NBRV
0.04000
(2.84%)
1.45000 USD
P
PDSB
-0.34000
(-9.52%)
3.23000 USD
P
PRQR
-0.10000
(-5.24%)
1.81000 USD
T
TNXP
0.00960
(1.92%)
0.51050 USD
T
TRVN
-0.00830
(-3.91%)
0.20390 USD
الأخبار المقالات

العنوان: IDEAYA Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.